This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 Oct;27(4):249-55.

doi: 10.2165/00003088-199427040-00001.

Chirality in new drug development. Clinical pharmacokinetic considerations

R L Nation¹

Affiliations

PMID: 7834962
DOI: 10.2165/00003088-199427040-00001

Review

Chirality in new drug development. Clinical pharmacokinetic considerations

R L Nation. Clin Pharmacokinet. 1994 Oct.

. 1994 Oct;27(4):249-55.

doi: 10.2165/00003088-199427040-00001.

Author

R L Nation¹

Affiliation

¹ School of Pharmacy and Medical Science, University of South Australia, Adelaide.

PMID: 7834962
DOI: 10.2165/00003088-199427040-00001

No abstract available

PubMed Disclaimer

Similar articles

Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.
Brocks DR. Brocks DR. Biopharm Drug Dispos. 2006 Nov;27(8):387-406. doi: 10.1002/bdd.517. Biopharm Drug Dispos. 2006. PMID: 16944450 Review.
Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
Chen ML. Chen ML. Clin Pharmacol Ther. 2005 Oct;78(4):322-9. doi: 10.1016/j.clpt.2005.06.012. Clin Pharmacol Ther. 2005. PMID: 16198651 Review. No abstract available.
Pediatric drug development: formulation considerations.
Ali AA, Charoo NA, Abdallah DB. Ali AA, et al. Drug Dev Ind Pharm. 2014 Oct;40(10):1283-99. doi: 10.3109/03639045.2013.850713. Epub 2014 Jan 31. Drug Dev Ind Pharm. 2014. PMID: 24483293 Review.
[Chiral switch: towards a better benefit-risk ratio?].
Blin O. Blin O. Therapie. 2004 Nov-Dec;59(6):625-8. doi: 10.2515/therapie:2004108. Therapie. 2004. PMID: 15789826 Review. French.
Lead optimization strategies as part of a drug metabolism environment.
Korfmacher WA. Korfmacher WA. Curr Opin Drug Discov Devel. 2003 Jul;6(4):481-5. Curr Opin Drug Discov Devel. 2003. PMID: 12951811 Review.

See all similar articles

Cited by

Stereoselective HPLC assay of TJ0711 enantiomers by precolumn derivatization with GITC using UV detection and its application in pharmacokinetics in rats.
Sun S, Si L, Fan Z, Qiu J, Li G. Sun S, et al. J Huazhong Univ Sci Technolog Med Sci. 2009 Aug;29(4):427-30. doi: 10.1007/s11596-009-0407-7. Epub 2009 Aug 7. J Huazhong Univ Sci Technolog Med Sci. 2009. PMID: 19662356
The cost benefit ratio of enantiomeric drugs.
Pifferi G, Perucca E. Pifferi G, et al. Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):15-25. doi: 10.1007/BF03192284. Eur J Drug Metab Pharmacokinet. 1995. PMID: 7588989 Review.
Clinical pharmacokinetics of dexketoprofen.
Barbanoj MJ, Antonijoan RM, Gich I. Barbanoj MJ, et al. Clin Pharmacokinet. 2001;40(4):245-62. doi: 10.2165/00003088-200140040-00002. Clin Pharmacokinet. 2001. PMID: 11368291 Review.
A chiral HPLC and pharmacokinetic approach of 1-(4-bromophenyl)-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide.
Mounika P, Shelby M, K S C, Kumar HY, Gurupadayya B. Mounika P, et al. Bioanalysis. 2025 Apr;17(7):445-453. doi: 10.1080/17576180.2025.2481023. Epub 2025 Mar 24. Bioanalysis. 2025. PMID: 40126089
Chirality and drugs used in psychiatry: nice to know or need to know?
Lane RM, Baker GB. Lane RM, et al. Cell Mol Neurobiol. 1999 Jun;19(3):355-72. doi: 10.1023/a:1006997731966. Cell Mol Neurobiol. 1999. PMID: 10319192 Free PMC article. Review.

References

1. Chirality. 1990;2(3):129-33 - PubMed
1. Biochem Soc Trans. 1991 Apr;19(2):443-6 - PubMed
1. Clin Pharmacol Ther. 1988 Apr;43(4):436-41 - PubMed
1. Drugs. 1985 Oct;30(4):333-54 - PubMed
1. Clin Pharmacol Ther. 1985 Jul;38(1):71-6 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information